BRNS vs CMS · rev $15.0M vs P/E 20, $22.42B cap
Barinthus Biotherapeutics plc (BRNS) versus CMS Energy Corporation (CMS) — a side-by-side from cached financials, not a winner call.
Barinthus Biotherapeutics plc (BRNS) is a biotechnology company listed on US.
CMS Energy Corporation (CMS) is a utilities - regulated electric company listed on US.
Latest reported BRNS revenue for 2024-12-31 was $15.0M. Net income was -$61.2M. Revenue was up 1766.5% from 2023-12-31 to 2024-12-31. BRNS currently screens at market cap $38.2M.
CMS does not have a complete income-statement cache yet.
BRNS currently screens at market cap $38.2M. CMS currently screens at market cap $22.42B and trailing P/E 20.1.
Not investment advice. Open the BRNS and CMS stock pages for the full models.
Not investment advice.